A new Beginning..., page-3413

Exactly right Clarky this is the reason why their share price didn't hold up today and their market capitalisation is quite low. They were issued a 510k clearance because their product is not revolutionary like so many other companies that obtain FDA clearance they have initial spike and then tend to drift... Companies like ResApp will do the opposite... ResApp has applied for De Novo application because our product IS revolutionary. The big difference is we will have first mover advantage no competition using a smartphone without any additional hardware. HUGE market to diagnose. 900 million doctor visits alone in the US estimated 30 to 40% of those visits are respiratory related HUGE! Growing trend in telehealth. Currently no other alternative in telehealth to diagnose respiratory disease accurately without any additional hardware, the current diagnosing method is more or less a coin toss.. many other useful uses like triage... FDA certification is likely imminent IMO.

Yep Roche would be all over this maybe Tim Jaeger is becoming a substantial shareholder for all we know... something is brewing IMO...

Cheers

Red bar